(c) 2023 PillSync.com

Trientine hydrochloride 250 MG Oral Capsule

INDICATIONS AND USAGE Trientine Hydrochloride Capsule is indicated in the treatment of patients with Wilson's disease who are intolerant of penicillamine. Clinical experience with Trientine Hydrochloride Capsule is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient's dose have not been well defined. Trientine Hydrochloride Capsule and penicillamine cannot be considered interchangeable. Trientine hydrochloride Capsule should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. Unlike penicillamine, Trientine Hydrochloride Capsule is not recommended in cystinuria or rheumatoid arthritis. The absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. In 15 patients with rheumatoid arthritis, Trientine Hydrochloride Capsule was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks of treatment. Trientine Hydrochloride Capsule is not indicated for treatment of biliary cirrhosis.

Navinta LLC


3 years ago CAPSULE ORANGE NAV 101 Trientine hydrochloride 250 MG Oral Capsule

CAPSULE ORANGE NAV 101

HOW SUPPLIED

TRIENTINE HYDROCHLORIDE Capsules, USP 250 mg, are hard gelatin capsules with opaque orange cap imprinted with NAV and opaque white body imprinted with 101 in black ink. They are supplied as follows: NDC 68475-200-01 in bottles of 100.

More pills like CAPSULE NAV 101












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site